Compound 403
Identifiers
- Canonical SMILES:
CNC(=O)c1ccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c(F)c1
- IUPAC name:
4-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-3-fluoro-N-methylbenzamide
- InChi:
InChI=1S/C23H26FN3O4/c1-15-14-26(23(30)17-7-5-4-6-8-17)11-12-27(15)22(29)16(2)31-20-10-9-18(13-19(20)24)21(28)25-3/h4-10,13,15-16H,11-12,14H2,1-3H3,(H,25,28)/t15-,16-/m1/s1
- InChiKey:
DLVMAUPKVXGJIH-HZPDHXFCSA-N
External links
168318225 |
24632575 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 5.70 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 427.19 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 2.06 | |||
TPSA | 78.95 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6048 | Tiropramide | DB13091 | |
0.5868 | Fipexide | DB13790 | |
0.5641 | Troxipide | DB13419 | |
0.5577 | Bavisant | DB12299 | |
0.5556 | Itopride | DB04924 | |
0.5524 | Aniracetam | DB04599 | |
0.5454 | Safinamide | DB06654 | |
0.5357 | Trimethobenzamide | DB00662 | |
0.5310 | OTX-008 | DB13123 | |
0.5299 | PF-04418948 | DB12024 | |
0.5243 | 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide | DB01827 | |
0.5234 | AZD-1305 | DB11766 | |
0.5221 | 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE | DB08608 | |
0.5211 | 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE | DB06869 | |
0.5203 | LY-2456302 | DB12341 |